Share This
Create Your Own Business Intelligence Website
 
Input the stock code or the company name     Search  

<03320.HK> - CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED

 
 
 Basic Datum
Company name Lot P/E P/B EPS DPS
CHINARES PHARMA 500 7.67 0.6085 0.6687 0.1688
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
04-19 Morgan  CHINARES PHARMA 增持8
04-19 Morgan  CHINARES PHARMA 增持2.6
03-27 htisec  CHINARES PHARMA 優於大市8.12
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2018-03-04 華潤集團旗下的華潤醫藥(3320)是內地第五大醫藥製造商、第一大非處方藥製造商,業務涵蓋醫藥產品的研發、生產和銷售,包括化學藥品、中藥、生物制劑以及營養保健品。產品組合覆蓋心血管、消化道和新陳代謝、兒科及呼吸系統等。
 
2018-03-04 華潤集團董事長傅育寧表示,華潤集團在醫療板塊上就混改或有新突破,但他否認與員工持股有關,華潤旗下有多間上市公司,當中已實現了員工持股。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 04-23 15:47 16813.8  302.16  1.83%
CHINARES PHARMA 04-26 14:37 5.04  5.04  ∞%
≫More
 
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.